Moxifloxacin Solution
Product Images NDC 68180-421

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Moxifloxacin (NDC 68180-421). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2c774519 5c69 4c3b 899d 7f8d1c5df1f3 01

FDA Label Image

2c774519 5c69 4c3b 899d 7f8d1c5df1f3 02

2c774519 5c69 4c3b 899d 7f8d1c5df1f3 02
This is a prescription drug with NDC code 68180-421-01. It is an ophthalmic solution intended for use in the eyes only. The drug is moxifloxacin manufactured by Lipin Ltd. The lot number is not available, but the expiration date is June 28, 2010. There is also an additional code, LUPIN amL 259928, that is possibly related to the production of the drug.*
FDA Label Image

2c774519 5c69 4c3b 899d 7f8d1c5df1f3 03

2c774519 5c69 4c3b 899d 7f8d1c5df1f3 03
Description: This is a description of an ophthalmic solution medication named Moxifloxacin. It contains sorbitol, tyloapol, santhan gum, hydrochloric acid, sodium yiroida 1 st o, and vt npton. The usual dosage is strop i aloctod oyt 2 times a day for 7 days. It should be stored at 2” b 20 (3 7. The medication is manufactured by Lupin Pharmaceuticals in Baltimore, Maryland. Batch coding and other details are usually printed at the plant.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.